1,976
Views
7
CrossRef citations to date
0
Altmetric
Research Article

New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic–photothermal therapy

, , , , , , & show all
Pages 1769-1784 | Received 13 May 2021, Accepted 19 Jul 2021, Published online: 02 Sep 2021

References

  • Baldea I, Olteanu DE, Bolfa P, et al. (2016). Melanogenesis and DNA damage following photodynamic therapy in melanoma with two meso-substituted porphyrins. J Photochem Photobiol B 161:402–10.
  • Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
  • Camerin M, Moreno M, Marin MJ, et al. (2016). Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma. Photochem Photobiol Sci 15:618–25.
  • Chauhan DS, Prasad R, Devrukhkar J, et al. (2018). Disintegrable NIR light triggered gold nanorods supported liposomal nanohybrids for cancer theranostics. Bioconjug Chem 29:1510–8.
  • Cheng L, Wang C, Feng L, et al. (2014). Functional nanomaterials for phototherapies of cancer. Chem Rev 114:10869–939.
  • Danhier F, Le Breton A, Preat V. (2012). RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9:2961–73.
  • Denkova AG, de Kruijff RM, Serra-Crespo P. (2018). Nanocarrier-mediated photochemotherapy and photoradiotherapy. Adv Healthc Mater 7:e1701211.
  • Donohoe C, Senge MO, Arnaut LG, Gomes-da-Silva LC. (2019). Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity. Biochim Biophys Acta Rev Cancer 1872:188308.
  • Fan Z, Chang Y, Cui C, et al. (2018). Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy. Nat Commun 9:2605.
  • Gajbhiye KR, Gajbhiye V, Siddiqui IA, Gajbhiye JM. (2019). cRGD functionalised nanocarriers for targeted delivery of bioactives. J Drug Target 27:111–24.
  • Gui C, Cui DX. (2012). Functionalized gold nanorods for tumor imaging and targeted therapy. Cancer Biol Med 9:221–33.
  • Hamzah J, Kotamraju VR, Seo JW, et al. (2011). Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 108:7154–9.
  • Huang HC, Rege K, Heys JJ. (2010). Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods. ACS Nano 4:2892–900.
  • Kalyane D, Raval N, Maheshwari R, et al. (2019). Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl 98:1252–76.
  • Kennedy LC, Bickford LR, Lewinski NA, et al. (2011). A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 7:169–83.
  • Kim M, Sahu A, Kim GB, et al. (2018). Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis. J Control Release 269:337–46.
  • Kwiatkowski S, Knap B, Przystupski D, et al. (2018). Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098–107.
  • Li B, Wang F, Gui L, et al. (2018). The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine 13:2099–118.
  • Li W, Zhang H, Guo X, et al. (2017). Gold nanospheres-stabilized indocyanine green as a synchronous photodynamic–photothermal therapy platform that inhibits tumor growth and metastasis. ACS Appl Mater Interfaces 9:3354–67.
  • Li X, Lovell JF, Yoon J, Chen X. (2020). Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol 17:657–74.
  • Li Z, Huang P, Zhang X, et al. (2010). RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm 7:94–104.
  • Lino RLB, Dos Santos PK, Pisani GFD, et al. (2019). Alphavbeta3 integrin blocking inhibits apoptosis and induces autophagy in murine breast tumor cells. Biochim Biophys Acta Mol Cell Res 1866:118536.
  • Liu C, Wu T, Wang S, et al. (2020). Anticancer effect of LS-HB-mediated photodynamic therapy on hepatocellular carcinoma in vitro and in vivo. Photodiagn Photodyn Ther 30:101718.
  • Liu L, Xie HJ, Mu LM, et al. (2018a). Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy. Int J Nanomedicine 13:8119–35.
  • Liu M, Zheng C, Cui M, et al. (2018b). Graphene oxide wrapped with gold nanorods as a tag in a SERS based immunoassay for the hepatitis B surface antigen. Mikrochim Acta 185:458.
  • Liu Y, Crawford BM, Vo-Dinh T. (2018c). Gold nanoparticles-mediated photothermal therapy and immunotherapy. Immunotherapy 10:1175–88.
  • Mehraban N, Freeman HS. (2015). Developments in PDT sensitizers for increased selectivity and singlet oxygen production. Materials 8:4421–56.
  • Melancon MP, Zhou M, Li C. (2011). Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 44:947–56.
  • Miller SE, Veale RB. (2001). Environmental modulation of alpha(v), alpha(2) and beta(1) integrin subunit expression in human oesophageal squamous cell carcinomas. Cell Biol Int 25:61–9.
  • Mioc A, Mioc M, Ghiulai R, et al. (2019). Gold nanoparticles as targeted delivery systems and theranostic agents in cancer therapy. Curr Med Chem 26:6493–513.
  • Mohammadi Z, Sazgarnia A, Rajabi O, et al. (2013). An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles. Photodiagn Photodyn Ther 10:382–8.
  • Ruoslahti E, Bhatia SN, Sailor MJ. (2010). Targeting of drugs and nanoparticles to tumors. J Cell Biol 188:759–68.
  • Tanaka Y, Mimori K, Shiraishi T, et al. (2000). alpha6 integrin expression in esophageal carcinoma. Int J Oncol 16:725–9.
  • Tian B, Wang C, Zhang S, et al. (2011). Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5:7000–9.
  • Wang B, Wang JH, Liu Q, et al. (2014). Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials 35:1954–66.
  • Wang F, Li Y, Shen Y, et al. (2013a). The functions and applications of RGD in tumor therapy and tissue engineering. Int J Mol Sci 14:13447–62.
  • Wang S, Huang P, Nie L, et al. (2013b). Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater 25:3055–61.
  • Weber MR, Zuka M, Lorger M, et al. (2016). Activated tumor cell integrin alphavbeta3 cooperates with platelets to promote extravasation and metastasis from the blood stream. Thromb Res 140 Suppl.1:S27–S36.
  • Xiao Q, Zheng X, Bu W, et al. (2013). A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. J Am Chem Soc 135:13041–8.
  • Xu H, Liu C, Mei J, et al. (2012a). Effects of light irradiation upon photodynamic therapy based on 5-aminolevulinic acid–gold nanoparticle conjugates in K562 cells via singlet oxygen generation. Int J Nanomedicine 7:5029–38.
  • Xu W, Luo T, Li P, et al. (2012b). RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating alpha(v)beta(3) expression. Int J Nanomedicine 7:915–24.
  • Yang K, Feng L, Shi X, Liu Z. (2013). Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 42:530–47.
  • Yang S, Chen C, Qiu Y, et al. (2021). Paying attention to tumor blood vessels: cancer phototherapy assisted with nano delivery strategies. Biomaterials 268:120562.
  • Zhang S, Lv H, Zhao J, et al. (2019). Synthesis of porphyrin-conjugated silica-coated Au nanorods for synergistic photothermal therapy and photodynamic therapy of tumor. Nanotechnology 30:265102.
  • Zheng Y, Ji S, Czerwinski A, et al. (2014). FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues. Bioconjug Chem 25:1925–41.